INTRODUCTION
Mitotic cells are profoundly altered in their membrane functions: pinocytosis [1] , exocytosis [2, 3] , receptor recycling [4, 5] and Ca2+ influx induced by hormones [6, 7] are strongly inhibited. We have studied these changes to suggest new ways in which membrane functions can be regulated [6, 8] . In this study, we show that the mobilization of arachidonate in response to hormones is strongly inhibited in mitotic cells. This places significant constraints on the physiological consequences ofhormone stimulation in mitotic cells and, at the same time, presents a natural model in which the regulation of arachidonate mobilization can be examined.
The production of arachidonic acid is generally held to be the rate-limiting step in the formation of eicosanoids such as the prostaglandins, and is essential for the actions of cytokines and diverse hormones (e.g. [9] [10] [11] [12] ). The release of arachidonic acid from phospholipid depends primarily on the activation of an arachidonic acid-selective cytosolic phospholipase A2 (cPLA2). It has recently become clear from studies with the purified selective cPLA2 that maximal activation is dependent on the synergistic actions of at least two factors: an elevation of intracellular free calcium ([Ca2+]1), which is essential for catalysis and appears to promote the translocation of the cytosolic enzyme to its membrane substrate [13, 14] , and specific phosphorylation of the enzyme [10, 15] , probably by MAP (mitogen-activated protein) kinase [16] . However, there are other sites of phosphorylation [15] . Moreover, it is unclear if phosphorylation and free Ca2+ levels can account for the entire regulation of cPLA2 in vivo.
It is reasonable to expect that Ca2+-dependent arachidonate cPLA2, we determined if the responses of mitotic HeLa cells could be modified by this 'priming' process. We first established that epidermal growth factor and phorbol 12-myristate 13-acetate were effective priming agents in interphase cells: cells preincubated with the hormone or tumour promoter showed a 2-fold stimulation of thapsigargin-or A23187-induced arachidonic acid release. However, none of the priming agents reversed the lack of mitotic cell response. This refractoriness was not caused by destruction of cPLA2 during mitosis: by Western blotting, cPLA2of interphase and mitotic cells was shown to be present in comparable amounts. Moreover, cPLA2 activities measured in extracts of interphase and mitotic cells were also comparable. Surprisingly, mitotic cPLA2 appeared to be constitutively phosphorylated in non-hormone-treated (control) cells. The results indicate a novel mechanism of regulation of cPLA2 activity in mitotic cells.
mobilization will be affected during mitosis. The hormoneinduced elevation of cytosolic free Ca2+ is not sustained by mitotic cells [6, 7] . Whereas during interphase depletion of intracellular Ca2+ stores induces Ca2+ influx (capacitive coupling [17] ), during mitosis, depletion of Ca2+ stores does not induce Ca2+ influx [6] . The Ca2+-dependent translocation of cPLA2 to the membrane, and catalysis, are therefore likely to be inhibited in mitotic cells. In addition, several protein kinases, some with broad substrate specificity, are specifically activated during mitosis [18, 19] , raising the possibility that the phosphorylationdependent regulation of cPLA2 might also be altered in mitotic cells. We show here that Ca2+-dependent arachidonate mobilization is, indeed, strongly inhibited in metaphase-arrested HeLa cells. More 
Preparation of metaphase-arrested and Interphase cell suspensions
HeLa-S3 cells were seeded at 105 cells/ml on 100 mm Falcon tissue-culture dishes and grown in monolayer in F-12 medium (Ham's nutrient mix) supplemented with L-glutamine and 7.5 % FBS as previously described [6, 7] .
The following procedures resulted in minimal contamination of mitotic populations with interphase cells [6] . Mitotic cells were obtained after the addition ofcolcemid (0.1 ,ug/ml) to monolayers for 15 h, followed by detachment of the rounded-up cells by gentle shaking. This simple method provided nearly pure populations of mitotic cells (> 95 %, as determined by staining with Hoechst dye 33258 [4] ). To control for long drug exposure, in selected experiments (representative of each protocol described below), cells were first synchronized by single thymidine block, then collected by shake-off -16 h after removal of thymidine into colcemid, and held for only [1] [2] [3] [4] [5] . Using the method of lipid analysis described below, we found that < 1% of the cellassociated radioactivity was in non-esterified fatty acid. This was true for both mitotic and interphase populations, even in the presence of agents which stimulated arachidonate release. As shown by others [21] , the label was found in all classes of phospholipid. Further, the time course of uptake was similar to that reported for HeLa cells by Espe et al. [21] . In general, it was advantageous to avoid an additional incubation after cell harvesting by allowing incorporation of label during the overnight period used to prepare metaphase-arrested cells. Comparable labelling periods were used for interphase cells. The labelling procedure did not affect the pattern of release.
Labelled interphase and mitotic populations were centrifuged at 600 g for 5 min, washed in fresh growth medium, and resuspended at 106 cells/ml in F-12 with 7.5 % FBS buffered with 10 mM Na-Hepes, pH 7.4. To investigate the potential contribution of serum to fatty acid release, for selected experiments, cells were washed twice and resuspended in growth medium with decreased (0.5 %) serum, or in serum-free medium (buffered with 30 mM Na-Hepes) to which 1.0 mg/ml fatty-acid-free BSA was added [22] . (Albumin serves as an extracellular trap for released arachidonic acid). Under our conditions, the decrease or absence of serum did not significantly alter either the qualitative or quantitative pattern of agonist-stimulated [3H]arachidonic acid release. Therefore, unless specifically stated otherwise, arachidonic acid release data were gathered from samples with 7.5 % FBS at 37°C present throughout.
Samples (106 cells in 1.0 ml) in microfuge tubes were incubated at 37°C with appropriate stimuli or inhibitors for times indicated in the Figure legends, then centrifuged at 14000 g for 5 s to separate cells from medium. Samples of medium were removed for immediate determination of radioactivity, and cell and medium samples were processed for lipid analysis [23] .
Lipid analysis Both medium (0.2 ml samples) and cells (pelleted cells washed twice in ice-cold serum-free F-12 buffered with 30 mM Na-Hepes and supplemented with 1.0 mg/ml fatty-acid-free BSA, and then resuspended in 0.2 ml of this medium) were added to glass tubes containing 1.0 ml of methanol. Samples were vortex-mixed and kept at room temperature for 1 h to extract lipids. The methanol fraction was removed, and the aqueous phase was re-extracted to give a final methanol extraction volume of 2 ml. The methanol fraction was vortex-mixed with 2 ml of chloroform, followed by Preparation of cell extracts and measurement of cPLA2 activity in vitro With slight modification, extracts were prepared and cPLA2 activity was measured as described previously [22, 24] . At 24-48 h after plating, cells were washed and resuspended (106 cells/ml) in serum-free F-12 medium buffered with 30 mM NaHepes, pH 7.4, containing 1.0 mg of fatty-acid-free BSA/ml. Samples were incubated in this medium for 2 h at 37°C, after which stimulatory agents were added as indicated in the Results section and in Figure and Table legends and incubated for an additional 20 min. Cells were then washed three times by centrifugation in homogenization buffer (50 mM Hepes, pH 7.4, 250 mM sucrose, 1 mM EDTA and 1 mM EGTA), and the pellets resuspended in a small volume (200-400 ll) of homogenization buffer containing 2 mM phenylmethanesulphonyl fluoride, leupeptin and pepstatin (40 jig/ml each) and aprotinin (80 ug/ml). Samples were probe-sonicated on ice (two 20 s exposures to the tip of a Kontes micro ultrasonic cell disrupter, tune dial set on 5). The lysate was then centrifuged at 1000 g for 5 min to remove nuclei and debris. Cytosol samples were collected as supernatants obtained by centrifugation at 100 000 g for 1 h at 4 'C. The excess of Ca2+ chelators during preparation of the extracts is required to obtain maximal cPLA2 activity in the supernatant fraction by dissociating the enzyme from membranes [13, 22] . Protein in the extract was determined by the Bio-Rad assay [25] .
Substrate was prepared by drying down 1-stearoyl-2-[14C]-arachidonyl phosphatidylcholine under N2, and resuspending in dimethyl sulphoxide by vigorous vortex-mixing. Reaction mixtures (40 z1l total volume) were formed as follows: cell-free extract (34,l of extract adjusted with homogenization buffer to final concentrations in the range 0.3-1.0 mg/ml) was added to microfuge tubes containing 2,1 of substrate in dimethyl sulphoxide (-70000 c.p.m./tube, final concn. 15 uM); the reaction was initiated by addition of 4,1 of 40 mM CaCl2 in 30 mM Hepes, pH 7.5 (final concn. 4 mM Ca2+, 2 mM in excess of chelators). As reported [22] , Ca2+ was absolutely required for cPLA2 activity in the enzyme assay. DTT (5 mM) was present in either the extract or the reaction mixture. DTT destroys the secretory form of PLA2 [24, 26] and was used routinely in assays for cPLA2. However, in fact the extract activity was unaffected by DTT. The reaction was incubated at 37 'C for 15 min, and stopped by addition of 40 gl of an ice-cold quench solution [2 % (v/v) acetic acid in ethanol, containing 1.0 mg of arachidonic acid/ml]. Then 50,1 of this mixture was spotted on Whatman LK6D TLC plates, which were developed in the organic phase of ethyl acetate/iso-octane/water/acetic acid (55:75:100:8, by vol.). Lipids were detected with 12. Arachidonic acid was well resolved from the phospholipids, which remained at the origin. Relevant areas were scraped and counted for radioactivity by liquid scintillation. Areas corresponding to a diacylglycerol standard were also routinely scraped and counted, but contained only background radioactivity. Results are expressed as pmol of arachidonic acid released/min per mg of extraction protein. As indicated by Goldberg et al. [22] , under these conditions less than 10% of substrate was hydrolysed. Activity in the absence of cell-free extract was always less than 5 % of total activity, and was subtracted for each experiment.
To determine the effect of dephosphorylation of cPLA2 on its enzymic activity, the 100000 g supernatant fraction (60-90 ueg) resulting extent of dephosphorylation was inferred from Western blots (described below) in which the apparent molecular-mass 'shift' of cPLA2 associated with its phosphorylation can be revealed.
Immunoblotting
Cell extracts were prepared as described above; cytosol or membrane protein (50-100 ug) was resolved on SDS/7.5 %-polyacrylamide gels and blotted on to Immobilon membranes (Millipore). Blots were probed with monoclonal anti-cPLA2 (see under 'Materials'), incubated with anti-mouse antibody linked to horseradish peroxidase, and developed by ECL. To observe the mobility shift associated with phosphorylation ofcPLA2 [10] [10, 22, 34] . Priming by tumour necrosis factora (TNF-a) has been demonstrated in HeLa cells and is correlated with phosphorylation of cPLA2 [11] . We considered the possibility that the failure of mitotic HeLa cells to respond to Ca2+ might be the consequence of a block to phosphorylation that might be overcome by priming. Immunoblot analysis of interphase and mitotic cell extracts, using a specific monoclonal anti-cPLA2 as the primary antibody, is illustrated in Figure 3 . Each lane was loaded with equal amounts of protein. From densitometry of the cPLA2-staining region under conditions in which density was linear with dilution, it was determined that the mitotic and interphase extracts contained nearly identical amounts of cPLA2 mass expressed per mg of protein (mitotic, 107% of interphase, average of 3 experiments). Clearly, the amount of cPLA2 present in mitotic cells did not account for their unresponsiveness.
Mobility shift of cPLA2
The blots also provided important information on the phosphorylation ofcPLA2 which, as discussed above, contributes to its activation [10, 15, 16, 30] . Phosphorylated proteins characteristically are slowed in their mobility on SDS/PAGE. Several laboratories have shown that activation of cPLA2 is associated with its decreased mobility, and that this arises from phosphorylation (e.g. [10, 11, 16, 34] ). As reported by Hoeck et al. [11] in their study of TNF-a activation of HeLa cells, we found that an appreciable fraction of the cPLA2 in growing populations of interphase cells was present in the slower-migrating form (Figure 3a, lane 1) , even when they were incubated in the absence of serum for 2 h at 37 'C. A greater proportion of the cPLA2 was shifted to the more slowly migrating form after incubation with EGF ( Figure 3, lane 2) . By contrast, in mitotic cells, virtually all of the reactive material was in the slower-migrating band even before addition of hormone or ionophore (Figure 3a, lane 3) . EGF did not cause a hypershift of the cPLA2 band derived from mitotic cells (Figure 3a, lane 4) . That the mobility shift was indeed the consequence of phosphorylation was supported by the effect of incubating the extract with PAP before electrophoresis. As shown in Figure 3(b) , the phosphatase caused a large fraction of the mitotic PLA2 band to shift to the more rapidly migrating species. A similar pattern was seen for interphase cPLA2 (results not shown). Although increasing the concentration of PAP by as much as 3-fold enhanced the downward shift (results not shown), we could not find conditions in which the shift was completely reversed.
Thus the cPLA2 of mitotic cells was present in quantity and appeared to be constitutively phosphorylated in a way that was consistent with maximal priming. However, it was possible that in mitotic cells phosphorylation occurs on a residue indifferent or even inhibitory to activation, while still leading to a mobility shift. To determine the functional state of the enzyme in mitotic cells, we examined the activity of the enzyme in vitro, using extracts collected in parallel with electrophoresed samples. cPLA2 activity in extracts of interphase cells Extracts were made in the presence of EGTA to ensure that all enzyme was released from membrane [24] , and the assay was performed on 100 000 g supernatants. Western blots showed that in fact there was little or no cPLA2 present in the resulting cell pellets (results not shown). The assay was performed under standard conditions in high Ca21 [22, 24] ; as noted in the Experimental section, Ca2+ was absolutely essential for activity. The results are shown in Table 2 . The calculated activity was comparable with that reported for CHO and other cell lines [10, 22] . When interphase cells were treated with EGF immediately before preparation of the extract, activity measured in vitro was doubled, as reported for HER 14 cells [22] . This was approximately the same degree of stimulation measured as arachidonate release from intact interphase cells (Table 1) . As discussed above, the increase in activity was associated with a decrease in cPLA2 mobility on SDS/PAGE. In addition, phosphatase treatment decreased the activity in extracts by approx. 40 % ( Table 2 ). The loss of activity in controls after phosphatase treatment was consistent with the observed mobility shift in extracts of control cells that indicates a degree of constitutive phosphorylation.
cPLA2 activity In extracts of mitotic cells Surprisingly, the activity in extracts of mitotic cells was similar to that measured in extracts of interphase cells (Table 2 ). In fact, the activity in extracts of untreated mitotic cells, expressed per mg of cell protein, was nearly the same as that in extracts obtained from untreated (unprimed) interphase cells. Since the protein of the larger mitotic cell is, of course, greater in amount than that of the interphase cell, the activity per cell is actually greater for the mitotic.
cPLA2 activities in samples of the phosphatase-treated mitotic samples illustrated in Figure 3 (b) were decreased, like those of interphase cells, by roughly 40 % (Table 2 ). This indicates that at least part of the cPLA2 activity in mitotic extracts was promoted by phosphorylation. As all of the mitotic cPLA2 was mobilityshifted, it is suggested that mitotic cPLA2 was already 'primed'. This is consistent with the observation that preincubation of mitotic cells with EGF did not result in the stimulation of phospholipase activity measured in vitro (Table 2) .
However, the level of 'primed' activity in mitotic extracts was no greater than in control interphase extracts. Thus it is possible that the mitotic cPLA2 is phosphorylated, and therefore, mobility-shifted, but at site(s) that do not enhance, and may actually block, the priming of enzyme activity.
DISCUSSION
cPLA2 is known to be activated by the synergistic actions of Ca2+ and specific protein phosphorylation [10, [13] [14] [15] [16] . The present paper, comparing mitotic and interphase HeLa cells, indicates the existence of yet other mechanisms of control.
We show that arachidonate mobilization in interphase HeLa cells reflects parallel phenomena described in CHO cells, fibroblasts and other cultured cell lines (e.g. [10, 11, 22, 24, 30, 34] ). Arachidonate release rapidly followed the addition of hormones or ionophores that raise [Ca2+],, and the release was blocked by Ca2+ chelators that prevent Ca2+ entry or buffer intracellular free Ca2+. These results are consistent with the known relationship of ligand-stimulated release and the actions of cPLA2 (as opposed to the recently described non-Ca2+-dependent PLA2 [35, 36] chelators, a fraction of cPLA2 is found associated with membranes. Indeed, Channon and Leslie [13] showed clearly that the extent of cPLA2 association with membrane was a function of the Ca2+ concentration of the homogenization buffer. Consistent with this, we did find (results not shown) that, when either interphase or mitotic cells were homogenized in buffers without chelators, a fraction of cPLA2 was associated with membrane. Thus, to measure total cPLA2 in extracts, Ca2+ chelators were used to reverse enzyme translocation, so that all activity could be brought into a supernatant fraction devoid of interfering endogenous membrane. The membrane association in the absence of chelators suggests that a fraction of cPLA2 could bind to the homogenized biological membranes of either interphase or mitotic cells, but this does not indicate that translocation actually occurs within the intact cell, in which the integrity and topological organization of membranes are preserved.
Despite the similarity in cPLA2 activities in interphase and mitotic cells, there were important differences in cPLA2 revealed in our studies: (1) as determined by mobility on Western blots, the amount of interphase cPLA2 shifted was increased on preincubation with EGF; mitotic cPLA2 was entirely shifted even before incubation with the priming agent, and (2) the activity in vitro of interphase cPLA2 was enhanced by preincubation with EGF; cPLA2 activity in mitotic extracts was unaffected by preincubation with EGF. These findings are consistent with the hypothesis that the mitotic cPLA2 is already primed. It has been established that, in interphase cells, priming is associated with phosphorylation on Ser-505, probably mediated by MAP kinase [16] . Although MAP kinase activity appears to reach a peak in late G2 (perhaps the G2/M transition), MAP kinase activity falls to very low levels in metaphasearrested CHO cells [39] . Assuming that metaphase-arrested HeLa cells behave similarly to CHO cells, this implies that MAP kinase release of Ca2+ from intracellular stores directly (thapsigargin), reaches minimum levels at a time when cPLA2 is heavily phosphorylated (mobility-shifted). Several explanations for this paradox are suggested, and remain to be resolved: one is that cPLA2 is phosphorylated by MAP kinase when cells enter mitosis, and dephosphorylation occurs only slowly as cells progress through mitosis, and another is that the mobility shift results from phosphorylation at an independent site mediated by other (perhaps mitosis-specific) protein kinases.
In any event, a cPLA2 that is Ca2+-activatable in extracts, but not in situ, suggests a novel regulatory mechanism in mitotic cells. There may be inhibition by lipocortin [40] , or some other inhibitor, that is diluted in extracts. Alternatively, there may be functional compartmentalization of cPLA2 or its substrates related to membrane reorganization in mitotic cells [38] . These interesting possibilities remain to be investigated.
Finally, it is clear that, as for many important physiological processes, the signal pathways leading to the mobilization of arachidonate are governed by multiple layers of control that are uniquely manifest in mitotic cells. Not only is the activity of cPLA2 in mitotic cells inhibited because elevated levels of [Ca2+]1 are not sustained by stimulated Ca2+ influx [6, 7] , but in vivo, even when Ca2+ is provided, arachidonic acid is not released. As arachidonate mobilization is the limiting first step in the formation of biologically active eicosanoids, mitotic cells will therefore not generate these regulatory factors.
